DMIC
NVO

Dixon Mitchell Investment Counsel’s Novo Nordisk NVO Stock Holding History

Dixon Mitchell Investment Counsel’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-50
Closed -$2.54K – 156
2025
Q4 		$2.54K Buy
+50
New +$2.56K ﹤0.01% 141
2024
Q3 		– Sell
-130
Closed -$18.6K – 137
2024
Q2 		$18.6K Sell
130
-70
-35% -$9.28K ﹤0.01% 92
2024
Q1 		$25.9K Buy
+200
New +$23.8K ﹤0.01% 103

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Dixon Mitchell Investment Counsel's NVO Position: Q1 2026 in Review

Dixon Mitchell Investment Counsel sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 50 shares — an estimated $2.54K sold.

Dixon Mitchell Investment Counsel first reported a position in NVO in Q1 2024 and held it in 3 quarters. The position peaked at $25.9K in Q1 2024. 1,274 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Dixon Mitchell Investment Counsel reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Dixon Mitchell Investment Counsel sold 50 Novo Nordisk shares in Q1 2026, an estimated $2.54K.
  • Dixon Mitchell Investment Counsel first reported a position in Novo Nordisk in Q1 2024 and held it in 3 quarters.
  • Dixon Mitchell Investment Counsel's Novo Nordisk position peaked at $25.9K in Q1 2024.
  • 1,274 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Dixon Mitchell Investment Counsel's 13F filing for Q1 2026, filed 14 May 2026.